Vis enkel innførsel

dc.contributor.advisorHopstock, Laila Arnesdatter
dc.contributor.authorHagen, Amalie Nilsen
dc.date.accessioned2023-02-03T15:34:54Z
dc.date.available2023-02-03T15:34:54Z
dc.date.issued2023-02-20
dc.description.abstractCardiovascular disease (CVD) is a major cause of mortality and morbidity, calling for an active preventive approach. Elevated blood pressure and cholesterol, smoking, diabetes, unhealthy diet, inactivity, and obesity are key risk factors for CVD development. Several risk factors combined may put an individual at a high total CVD risk. To measure total CVD risk, we used the NORRISK 2 score that estimates the 10-year risk of fatal and non-fatal myocardial infarction and stroke. This thesis used data from the population-based Tromsø Study, Tromsø6 (2007-2008), and Tromsø7 (2015-2016) to study total CVD risk and primary prevention in the general population. We observed a decline in total CVD risk during the time period and a change in the distribution from higher to lower risk categories. The NORRISK 2 score and the current primary prevention guidelines increase the population proportion at risk by 3.4 percentage points compared to the former risk score and guideline. Individuals with a high risk of CVD experienced several favourable changes in CVD risk factors between Tromsø6 and Tromsø7. However, less than 1 in 10 achieved all blood pressure, lipids, and smoking treatment targets combined. Individuals with the highest risk of CVD have the lowest probability of achieving treatment targets. Our results showed that medication use was the most important factor associated with target achievement. We have demonstrated a potential for improvement in the primary prevention of CVD, and more attention and closer follow-up of high-risk individuals are needed.en_US
dc.description.doctoraltypeph.d.en_US
dc.description.popularabstractCardiovascular disease (CVD) is a common reason for illness and death. Elevated blood pressure and cholesterol, smoking, diabetes, unhealthy diet, inactivity, and obesity are known risk factors. Several risk factors combined can put an individual at high total risk for CVD. The NORRISK 2 score calculates the 10-year risk of an acute heart attack, stroke, or death due to CVD. We used data from the population-based Tromsø Study; Tromsø6 (2007-2008) and Tromsø7 (2015-2016). Our results showed that total CVD risk declined in the time period. Less individuals were identified as having high total risk of CVD. More individuals were defined as having a high total risk of CVD using NORRISK 2 and the current guidelines compared to the former risk score and guidelines. Less than 1 in 10 high risk individuals reached treatment targets. Medication use was the most important factor associated with target achievement. More attention and closer follow-up of high-risk individuals is needed.en_US
dc.description.sponsorshipHelse Norden_US
dc.identifier.urihttps://hdl.handle.net/10037/28493
dc.language.isoengen_US
dc.publisherUiT The Arctic University of Norwayen_US
dc.publisherUiT Norges arktiske universiteten_US
dc.relation.haspart<p>Paper I: Nilsen, A., Hansen, T.A., Lappegård, K.T., Eggen, A.E., Løchen, M.L., Njølstad, I., Wilsgaard, T. & Hopstock, L.A. (2019). Secular and longitudinal trends in cardiovascular risk in a general population using a national risk model: The Tromsø Study. <i>European Journal of Preventive Cardiology, 26</i>(17), 1852-1861. Also available at <a href=https://doi.org/10.1177/2047487319830806>https://doi.org/10.1177/2047487319830806</a>. <p>Paper II: Nilsen, A., Hansen, T.A., Lappegård, K.T., Eggen, A.E., Løchen, M.L., Selmer, R.M., Njølstad, I., Wilsgaard, T. & Hopstock, L.A. (2021). Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: The Tromsø Study 2015-2016. <i>OpenHeart, 8</i>(2), e001777. Also available in Munin at <a href=https://hdl.handle.net/10037/23175>https://hdl.handle.net/10037/23175</a>. <p>Paper III: Hagen, A.N., Ariansen, I., Hanssen, T.A., Lappegård, K.T., Eggen, A.E., Løchen, M.L., Njølstad, I., Wilsgaard, T. & Hopstock, L.A. (2022). Achievements of primary prevention targets in individuals with high risk of cardiovascular disease. An 8-year follow-up of the Tromsø Study. <i>European Heart Journal Open, 2</i>(5), oeac061. Also available in Munin at <a href=https://hdl.handle.net/10037/28414>https://hdl.handle.net/10037/28414</a>.en_US
dc.rights.accessRightsopenAccessen_US
dc.rights.holderCopyright 2023 The Author(s)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0en_US
dc.rightsAttribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801en_US
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Forebyggende medisin: 804en_US
dc.subjectVDP::Medical disciplines: 700::Health sciences: 800::Preventive medicine: 804en_US
dc.subjectTromsøundersøkelsenen_US
dc.subjectThe Tromsø Studyen_US
dc.titleCardiovascular disease: risk assessment, total risk, and primary prevention in the general population. Insights from the Tromsø Studyen_US
dc.typeDoctoral thesisen_US
dc.typeDoktorgradsavhandlingen_US


Tilhørende fil(er)

Thumbnail
Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
Med mindre det står noe annet, er denne innførselens lisens beskrevet som Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)